Avantor, Inc. (AVTR) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-03-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-03-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-03-31..
Borrowing debt
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 37.00M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 3.78B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 11.66B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | (m) | $37.00M | $3.78B | (m) | (m) | $11.66B | (m) |
| 2025-12-31 | (m) | (m) | $30.80M | $3.92B | (m) | (m) | $11.79B | (m) |
| 2025-09-30 | (m) | (m) | $219.80M | $3.64B | (m) | (m) | $11.68B | (m) |
| 2025-06-30 | (m) | (m) | $1.25B | $2.99B | (m) | (m) | $12.78B | (m) |
| 2025-03-31 | (m) | (m) | $827.50M | $3.28B | (m) | (m) | $12.33B | (m) |
| 2024-12-31 | (m) | (m) | $821.10M | $3.23B | (m) | (m) | $12.11B | (m) |
| 2024-09-30 | (m) | (m) | $229.70M | $4.69B | (m) | (m) | $12.84B | (m) |
| 2024-06-30 | (m) | (m) | $258.40M | $4.86B | (m) | (m) | $12.69B | (m) |
| 2024-03-31 | (m) | (m) | $299.10M | $5.02B | (m) | (m) | $12.76B | (m) |
| 2023-12-31 | (m) | (m) | $259.90M | $5.28B | (m) | (m) | $12.97B | (m) |
| 2023-09-30 | (m) | (m) | $335.60M | $5.29B | (m) | (m) | $12.80B | (m) |
| 2023-06-30 | (m) | (m) | $314.00M | $5.57B | (m) | (m) | $13.06B | (m) |
| 2023-03-31 | (m) | (m) | $325.20M | $5.74B | (m) | (m) | $13.40B | (m) |
| 2022-12-31 | (m) | (m) | $364.20M | $5.92B | (m) | (m) | $13.46B | (m) |
| 2022-09-30 | (m) | (m) | $280.60M | $5.91B | (m) | (m) | $13.11B | (m) |
| 2022-06-30 | (m) | (m) | $246.40M | $6.29B | (m) | (m) | $13.43B | (m) |
| 2022-03-31 | (m) | (m) | $44.70M | $6.82B | (m) | (m) | $13.84B | (m) |
| 2021-12-31 | (m) | (m) | $45.20M | $6.98B | (m) | (m) | $13.90B | (m) |
| 2021-09-30 | (m) | (m) | $37.00M | $5.55B | (m) | (m) | $12.20B | (m) |
| 2021-06-30 | (m) | (m) | $39.50M | $5.61B | (m) | (m) | $11.25B | (m) |
| 2021-03-31 | (m) | (m) | $26.50M | $4.61B | (m) | (m) | $9.74B | (m) |
| 2020-12-31 | (m) | (m) | $26.40M | $4.87B | (m) | (m) | $9.91B | (m) |
| 2020-09-30 | (m) | (m) | $14.40M | $5.06B | (m) | (m) | $9.94B | (m) |
| 2020-06-30 | (m) | (m) | $14.30M | $5.06B | (m) | (m) | $9.87B | (m) |
| 2020-03-31 | (m) | (m) | $14.30M | $5.04B | (m) | (m) | $9.79B | (m) |
| 2019-12-31 | (m) | (m) | $93.50M | $5.02B | (m) | (m) | $9.77B | (m) |
| 2019-09-30 | (m) | (m) | $41.40M | $5.09B | (m) | (m) | $9.76B | (m) |
| 2019-06-30 | (m) | (m) | $195.70M | $5.13B | (m) | (m) | $10.02B | (m) |
| 2018-12-31 | (m) | (m) | $142.40M | $6.78B | (m) | (m) | $9.91B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |